Loading...

150 posters, 16 sessions, 294 authors, 70 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

Obstetric Anaesthesia Annual Scientific Meeting 2024

Thursday 9 - Friday 10 May 2024, Birmingham

Obstetric Anaesthesia Annual Scientific Meeting 2024 banner

6285767

Remifentanil patient-controlled analgesia during labour: A service evaluation at our district general hospital

Part of Topic

Remifentanil patient-controlled analgesia during labour: A service evaluation at our district general hospital

Remifentanil is a potent, short-acting opioid with novel pharmacokinetic properties, making it effective for analgesia in labour when administered by intravenous patient-controlled analgesia (PCA). Many maternity units in the United Kingdom offer remifentanil PCA as an analgesic option in labour, but it is often restricted to circumstances when an epidural is contraindicated (1).

Warwick Hospital is a district general hospital with a busy maternity unit. We sought to evaluate our remifentanil PCA usage to determine the demand and safety of remifentanil PCA for analgesia in labour.

Obstetric Anaesthesia Annual Scientific Meeting 2024 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.